Ancilia Biosciences, Inc. funding
Ancilia Biosciences, Inc., a company based in New York, NY, filed a Form D with the SEC on April 6, 2026 and reported $10.1M raised.
Amount raised$10.1M
Offering size$10.1M
Filed with the SECApril 6, 2026
First saleFebruary 13, 2026
IndustryOther
SecuritiesEquity
LocationNew York, NY
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far23
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Apr 6
Other recent rounds in New York
Carter Investment Holdings, L.P.$112M · Oct 21OtherTrimtab Impact Inc.$52M · Sep 18OtherVulcan Infrastructure & Power Inc.$39.3M · Sep 24OtherSovereign Cultural Fund I, LP$35M · Oct 9OtherSG QC Holdings, LLC$31.8M · Oct 22OtherAdaptive Real Estate, Inc.$30M · Oct 28OtherOSP Burns Holdings, LP$23.1M · Sep 28OtherSG QC Investment, LLC$20.7M · Oct 22Other